Bausch Health Companies (BHC) Intangibles (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Intangibles came in at $4.4 billion in Q1 2026, down 16.86% year-on-year from $5.3 billion in Q1 2025, and down 5.15% quarter-over-quarter from $4.6 billion in Q4 2025.
Bausch Health Companies (BHC) Intangibles (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Intangibles across 18 years of filings, most recently posting $4.4 billion for Q1 2026.
- Intangibles for Q1 2026 came in at $4.4 billion, down 16.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 billion (down 16.86% YoY), and the FY2025 annual result was $4.6 billion, down 16.36% from the prior year.
- Intangibles came in at $4.4 billion for Q1 2026 at Bausch Health Companies, down from $4.6 billion in the prior quarter.
- In the past five years, Intangibles ranged from a high of $6.7 billion in Q3 2023 to a low of $4.4 billion in Q1 2026.
- The 5-year median for Intangibles is $5.7 billion (2024), against an average of $5.7 billion.
- Across the five-year window, Intangibles retreated 17.08% in 2022 and advanced 11.69% in 2023, its largest moves.
- Bausch Health Companies' Intangibles stood at $5.8 billion in 2022, then increased by 11.31% to $6.5 billion in 2023, then fell by 14.02% to $5.6 billion in 2024, then decreased by 16.36% to $4.6 billion in 2025, then slipped by 5.15% to $4.4 billion in 2026.
- The last three Intangibles figures came in at $4.4 billion (Q1 2026), $4.6 billion (Q4 2025), and $4.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.61 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 959.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 25.57 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.23 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.80 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 936.46 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 261.03 Mn |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | 4.40 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.40 Bn |
| Dec 31, 2025 | 4.64 Bn |
| Sep 30, 2025 | 4.83 Bn |
| Jun 30, 2025 | 5.05 Bn |
| Mar 31, 2025 | 5.30 Bn |
| Dec 31, 2024 | 5.55 Bn |
| Sep 30, 2024 | 5.65 Bn |
| Jun 30, 2024 | 5.90 Bn |
| Mar 31, 2024 | 6.18 Bn |
| Dec 31, 2023 | 6.46 Bn |
| Sep 30, 2023 | 6.73 Bn |
| Jun 30, 2023 | 5.30 Bn |
| Mar 31, 2023 | 5.55 Bn |
| Dec 31, 2022 | 5.80 Bn |
| Sep 30, 2022 | 6.02 Bn |
| Jun 30, 2022 | 6.32 Bn |
| Mar 31, 2022 | 6.63 Bn |
| Dec 31, 2021 | 6.95 Bn |
| Sep 30, 2021 | 7.26 Bn |
| Jun 30, 2021 | 7.62 Bn |